us stock futures traded slightly lower this morning on monday investors meanwhile focused on some notable insider trades when insiders purchase or sell shares it indicates their confidence or concern around the companys prospects investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision below is a look at a few recent notable insider transactions for penny stocks for more check out benzingas insider transactions platform3   the trade biocardia inc president and ceo peter altman acquired a total of 15000 shares at an average price of 124 to acquire these shares it cost 1859 thousand   what biocardia does biocardia inc is a clinical stage regenerative medicine company it is developing therapeutics for cardiovascular diseases with large unmet medical needs   the trade drive shack inc director wesley r edens acquired a total of 2000000 shares at an average price of 114 the insider spent around 227 million to buy those shares   what’s happening drive shack recently reported firstquarter fy22 sales growth of 129 yearonyear to 6898 million beating the consensus of 6540 million   what drive shack does drive shack inc is an owner and operator of golfrelated leisure and entertainment businesses the company conducts its business through three primary segments traditional golf properties entertainment golf venues and corporate also check this executives buy more than 90m of 4 stocks don’t forget to check out our premarket coverage here    the trade freightcar america inc 10 owner alejandro gil acquired a total of 52090 shares at an average price of 368 to acquire these shares it cost around 19148 thousand   what freightcar america does freightcar america inc is a diversified manufacturer of railcars and railcar components in north america the company design and manufacture a broad variety of freight cars including covered hoppers opentop hoppers gondolas intermodal and nonintermodal flat cars that transport numerous types of dry bulk and containerized freight products   the trade compass therapeutics inc 10 owner orbimed genesis gp llc acquired a total of 192516 shares at an average price of 218 the insider spent 42048 thousand to buy those shares   what compass therapeutics does compass therapeutics inc is a clinicalstage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies   the trade imedia brands inc director eyal lalo acquired a total of 390880 shares at an average price of 307 the insider spent 12 million to buy those shares   what’s happening imedia brands said it sees q1 sales of 154 million to 157 million   what imedia brands does imedia brands inc is a global interactive media company that manages a portfolio of shopping television networks and web service businesses primarily in north america for english and spanish speaking audiences